Literature DB >> 7011532

Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin.

J E Talmadge, M E Key, I R Hart.   

Abstract

We have studied the M5076 tumor, a transplantable murine reticulum cell sarcoma that arose spontaneously in the ovary of a C57BL/6 mouse. This tumor displays functional and ultrastructural characteristics indicating that it is of macrophage origin. Cells from the M5076 tumor are phagocytic, form rosettes with sheep red blood cells, mediate antibody-dependent cellular cytotoxicity against 51Cr-labeled red blood cells, and display macrophage-like cytotoxicity against syngeneic tumor target cells but do not exhibit any natural killer cell activity. The tumor cells possess lysozyme, nonspecific esterase, and phosphatase activities comparable to that seen in rodent macrophages. Ultrastructural examination revealed phagocytic vacuoles and a lack of tight junctions typical of macrophage morphology. Karyotype analysis showed that M5076 tumor cells are hypodiploid with a high percentage (greater than 80%) of metacentric chromosomes that serve as an excellent marker for identification of these tumor cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011532

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.

Authors:  N C Phillips; M S Tsao
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

3.  Cis-diamminedichloroplatinum sensitivity of murine reticulum sarcoma cells in primary culture and after in vitro passages.

Authors:  G Balconi; G Damia; F Morali; M Marzola; G Tagliabue; E Erba; M D'Incalci
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-08       Impact factor: 2.416

Review 4.  Developing new drugs for ovarian cancer: a challenging task in a changing reality.

Authors:  R M Canetta; S K Carter
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

5.  Selective killing of Fc-receptor-bearing tumor cells through endocytosis of a drug-carrying immune complex.

Authors:  W C Shen; H J Ryser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Mechanism of liver-specific metastatic tumor spread in a murine tumor model.

Authors:  G Edel
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Antitumor activity and mechanism of action of the marine compound girodazole.

Authors:  F Lavelle; A Zerial; C Fizames; B Rabault; A Curaudeau
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

Review 8.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

9.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 10.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.